Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.19.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Retained Earnings / Accumulated Deficit
Other Comprehensive Income / Loss
Total
Beginning balance, shares at Mar. 31, 2018 685,747        
Beginning balance, value at Mar. 31, 2018 $ 1,000 $ 176,740,000 $ (157,440,000) $ (3,975,000) $ 15,326,000
Issuance of common stock, net of commissions, expenses and other offering costs, shares 27,240 916     916
Stock based compensation related to issuance of common stock restricted stock grants, shares 1,764        
Stock based compensation related to issuance of common stock restricted stock grants, value   $ 45,000     $ 45,000
Stock-based compensation expense, net of forfeitures   302,000     302,000
Foreign currency translation adjustment       (502,000) (502,000)
Net income (loss)     (3,458,000)   (3,458,000)
Ending balance, shares at Jun. 30, 2018 714,751        
Ending balance, value at Jun. 30, 2018 $ 1,000 178,003,000 (160,898,000) (4,477,000) 12,629,000
Beginning balance, shares at Mar. 31, 2019 1,316,335        
Beginning balance, value at Mar. 31, 2019 $ 2,000 184,074,000 (169,238,000) (4,349,000) 10,489,000
Cumulative adjustment resulting from adoption of ASU at Jun. 30, 2019     (59,000)   (59,000)
Stock based compensation related to issuance of common stock restricted stock grants, shares 835        
Stock based compensation related to issuance of common stock restricted stock grants, value   20,000     20,000
Stock-based compensation expense, net of forfeitures   272,000     272,000
Foreign currency translation adjustment       67,000 67,000
Net income (loss)     715,000   715,000
Ending balance, shares at Jun. 30, 2019 1,317,170        
Ending balance, value at Jun. 30, 2019 $ 2,000 $ 184,366,000 $ (168,582,000) $ (4,282,000) $ 11,504,000